Ladenburg Thalmann analyst, Kevin DeGeeter, reiterated his Buy rating on shares of Opko Health (NASDAQ: OPK) after the company made ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE